logo
  • genedrive.com
  • About us
    • Company profile
    • Board of Directors
    • Advisors
    • Modern Slavery Statement
    • Net Zero Statement
    • Code of Conduct
    • Carbon Reduction Plan
  • Our product
  • News & Events
    • Press releases
    • Events
  • Careers
    • Careers
    • Applicants Privacy Notice
  • Investor relations
    • AIM Rule 26
    • Investor relations
    • Shareholders
    • Share price information
    • Regulatory news
    • Reports & presentations
    • Analyst notes
    • Constitutional documents
    • Investor news
    • Corporate governance
    • Investor contacts
    • Company information

AIM Rule 26

Home > Investor relations > AIM Rule 26

The information below is disclosed in accordance with AIM Rule 26 and details are updated on a regular basis:

Business Description – Click here 

Directors Names & Biographies - Click here

Corporate Governance – Click here

UK Takeover Code - The Company is subject to the UK City Code on Takeovers and Mergers.

Current constitutional documents such as articles of association and memorandum of association - Click here

Details of any other exchanges or trading platforms - The company’s shares are not traded on any other stock exchange.

The number of aim securities in issue (noting any held as treasury shares) – Click here 

The identity and percentage holdings of significant shareholders – Click here 

Details of any restrictions on the transfer of aim securities– Click here 

Annual and interim financial reports - – Click here 

Regulatory news – Click here 

Aim admission document and circulars - Click here 

Advisors – Click here

Country of incorporation: England and Wales
Company registration number: 09761507
Main country of operation: United Kingdom 

Latest reports

share price graph

05 December 2024

Annual Report and Accounts 2024

View all reports >

Investor News

Friday May 30, 2025

Genedrive wins EU approval for genetic test used in stroke care

Tuesday May 13, 2025

Genedrive test kits set for new NHS trial in Manchester

Tuesday August 06, 2024

genedrive shares down 10% after CEO departure

View all news >

BIVDA-stamp-2023
  • Privacy
  • Terms of use
  • Site map

© 2017-25 genedrive plc

genedrive plcThis site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.

Don't show this againclose